Researchers also found that FKBP51 acts as a cofactor of the IκB-kinase (IKK) complex, induces the activation of the NF-κB pathway and promotes the progression of prostate cancers, melanoma, and glioblastoma [22–25]. Here, NFKB1 is linked to melanoma.